Growth masks margin squeeze; subsidy revision now critical
Revenue climbed 15.9% to ₹8,165 Cr, but PAT collapsed 23.9% to ₹382 Cr and EBITDA flatlined despite price hikes. The margin crisis is real—and depends entirely on government action by Kharif.
₹8,165 Cr
+15.9% YoY
₹382 Cr
-23.9% YoY
₹761 Cr
-3% YoY (flat)
4.6%
vs. 6.1% prior year
The quarter exposed a hard limit: management can raise prices, but subsidy policy sets the floor on viability. Revenue up 16%, yet profit down 24%. EBITDA flat. The company delivered exactly what it promised the Street — but what it promised does not work without a government action that has not yet materialized.
The paradox: Why strong sales delivered weak profit
Fertilizer business delivered ₹8,055 Cr in revenue (77% of total consolidated), up 14% YoY. But the business ran at only 72% capacity (production 6.9 lakh tons vs. 8.4 lakh ton run-rate), and EBITDA from the segment was ₹761 Cr — essentially flat year-on-year despite the sales uplift. The math: company raised prices 25–30% across fertilizer grades this season. Volumes down 9–10%. Costs (ammonia, sulphur) held elevated. Subsidy received during the quarter, ₹1,392 Cr, was up 7% from ₹1,300 Cr in Q1 prior year. But outstanding subsidy as of June 30 stood at ₹3,254 Cr, and — crucially — Kharif rates had not yet been revised upward to reflect the Middle East crisis-driven inflation in raw materials.
Non-subsidy segments compensated: Crop Protection revenue ₹870 Cr (+20% YoY), EBIT ₹159 Cr (+44%). Retail revenue surged 85% on expanded network (1,200+ outlets, 76% unit profitability). But the fertilizer PAT collapse (driven by EBITDA compression and higher depreciation from backward integration capex commissioning) more than offset the wins.
Management claims: Graded against delivered results
Fertilizer business delivered very strong numbers in spite of headwinds
OverstatedRevenue +15.9%, but volumes down 9–10%, EBITDA flat ₹761 Cr vs. ₹782 Cr, PAT −24%
Crop Protection delivered record performance, revenue up 20% to ₹870 Cr, EBIT +44% to ₹159 Cr
SupportedActual results match claim exactly: ₹870 Cr revenue, ₹159 Cr EBIT confirmed
Backward integration will drive EBITDA per ton from ₹5,000 to ₹6,500 once normalized
ContradictedQ1 shows compression, not expansion. Target is aspirational; depends on subsidy revision & input normalization not yet delivered
Industry maintained consumption sales volumes despite subsidy lag
SupportedConsumption stable, farmers picked lower MRP packs early; point-of-sales up 13% to 7.9 lakh tons
What changed on this call
Subsidy revision hung: The company prior-call assumption was a 10% hike in NP/NPK subsidy rates. Instead, rates announced do not factor the Middle East crisis inflation. Industry production and imports fell 21% and 38% YoY respectively. Management is now in a holding pattern—prices already at ceiling, production throttled, waiting for policy to move. No timeline given; hedged language ('hopeful outcome coming').
Raw material inflation accelerated: Ammonia and sulphur remain elevated. Phosphoric acid Q2 settled at $1,700/ton vs. ₹1,360 Q1 (+25%). Management stated sulphur expected to remain high 'for some time,' declined to accept more supply at current levels. This is a downgrade from prior call's assumption of moderation.
Crop Protection momentum stronger: Guided 20–25% growth; delivered 20%, at the lower end. But EBIT +44% outpaced revenue growth due to better product mix and pricing power. Retail network now 1,200 outlets vs. prior baseline. This segment is compensating for fertilizer headwinds.
Backward integration on track, margin uplift deferred: PA-SA plants (phosphoric acid–sulphuric acid) commissioned as planned, stabilized in operations. Senegal BMCC mining producing 1.1 lakh tons rock phosphate (on plan). Granulation project commencing Q4. But management explicitly said the ₹5,000 → ₹6,500 EBITDA/ton journey depends on subsidy revision and input cost normalization — neither yet delivered. It's no longer 'next quarter' but 'normal situation required'.
The bull-bear ledger
Non-subsidy segments firing (CP +20%, Retail +85%, Specialty 25–30% growth YoY) — real diversification kicking in
Market share gains in primary fertilizer (22% vs. 18%) despite volume moderation — competitive moat intact
Backward integration capex now live (PA-SA, granulation Q4, Senegal mining); reduces raw material cost risk over time
PAT down 24% YoY despite 16% revenue growth — profitability has decoupled from topline
Subsidy revision (core assumption) not received; fertilizer production constrained to 72% capacity utilization
Outstanding subsidy ₹3,254 Cr as of June 30; working capital dynamics tied to government timing, not company execution
Management tone defensive; hedged language on subsidy ('hopeful') and inflation ('don't expect this quarter'; 'normal situation required')
Risks, ranked by holder concern
Subsidy revision delayed past Kharif season (Aug–Sep 2026)
HIGHCore assumption for volume recovery and margin stabilization. Without revision by monsoon season peak, fertilizer demand likely softens further (already 9–10% volume decline Q1). Further production cuts forced; price destruction risk.
Raw material inflation sustained longer than expected (sulphur, ammonia, phosphoric acid)
HIGHCompany already taken 25–30% price increases; farmer and channel affordability at ceiling. No more pricing room. If raw material costs stay elevated Q2+, margin compression worsens or demand destroys to offset cost.
Monsoon deficit persists (23% deficit early June, moderated to 17% by end; reservoir 34% capacity vs. 57% prior year)
MEDIUMKharif sowing momentum already visible, but sustained drought could dampen fertilizer offtake in Q2–Q3. Farmer purchase power weakens in drought years; shifts to cheaper grades or DAP (lower subsidy dependency for government but margin headwind for NPK producers).
Demand elasticity to price hikes exceeds company estimate (farmers shift to DAP or skip nutrient application)
MEDIUMManagement resisted analyst suggestion of demand destruction but acknowledged it 'can happen' if subsidy not corrected. Retail network (1,200 outlets) gives direct visibility, but large agri-dealer channel may see parallel-import or lower-MRP routing.
Capex ROI from backward integration disappoints (PA-SA acid costs don't decline as modeled; Senegal SSP business slow to scale)
MEDIUMINR7,000 Cr invested over 3–4 years; management now focused on 'cash generation first' (language suggests capex ROI scrutiny). If ₹5,000 → ₹6,500 EBITDA/ton uplift doesn't materialize, return on equity will compress.
How the Street is positioned
Stock down 17.02% from its all-time high of ₹2,499, now at ₹2,073.6. The day-1 post-result reaction was negative (−2.08%), a candid assessment of the PAT collapse; by day 5, the decline had moderated to +1.55%, suggesting partial recovery of confidence. The stock remains above its 20-day (₹2,038.74) and 50-day (₹1,958.53) simple moving averages but below the 200-day (₹2,115.49), placing it in a 'correction within an uptrend' posture.
Institution flows hint at caution. FII holdings declined 78 basis points to 13.02% in Q4 FY26 (from 14.29% a year earlier), while DII holdings rose 150 basis points to 18.20%. The shift suggests foreign portfolio investors are trimming exposure while domestic institutions (likely long-only funds) are adding on dips — a classic pattern when fundamentals are cloudy but near-term catalysts (subsidy revision) are material. Promoter shareholding stable at 56.35%.
The valuation drawdown is justified by the earnings miss — PAT down 24% is not a market overreaction. However, the stock's trading above key moving averages (20/50) signals the Street still expects a recovery if subsidy rates are revised by Kharif.
The debate
What to watch next
1 · Kharif subsidy rate announcement (Aug–Sep 2026)
Management awaiting finalization of NP/NPK rates. If announced in line with ammonia/sulphur inflation (target ₹6,000–₹7,000 EBITDA/ton for viability), volume recovery and margin stabilization follow. Timing critical — delayed past September softens demand signal.
2 · Q2 phosphoric acid pricing (expected ~$1,700 vs. Q1 $1,360)
Already marked up 25%. Will determine whether PA-SA backward integration capex begins yielding cost savings or if acid sourcing costs remain a margin headwind. Management expects 'softening' but timeline vague.
3 · Granulation project commissioning (Q4 FY27)
Capacity unlock for 750K ton NPK sales via retail (500K tons) and wholesale/new markets (350–400K tons). Volume recovery lever; depends on subsidy normalization to make economics work.
4 · Monsoon outturn and Kharif sowing momentum (Jul–Aug 2026)
Deficit has moderated (23% → 17%), and sowing picking up. Full-quarter normalization would signal on-ground demand recovery and validate subsidy revision assumption.
The number to track from here
Fertilizer EBITDA per ton — target ₹6,500 vs. current ~₹5,000. It's the single best proxy for whether the subsidy + backward integration thesis is working. Q1 showed compression, not expansion. If Q2 shows year-over-year expansion (even small, to ₹5,200–₹5,300/ton), it signals subsidy revision + input stabilization are real. If Q2 stays flat or compresses further, the recovery is being pushed to Q3+ and risk rises. Pair it with capacity utilization — back above 90% would confirm demand recovery; stuck at 75%+ signals structural weakness.
Coromandel is not in distress. Crop Protection and Retail are maturing into genuine growth engines. Backward integration capex will compound over 2–3 years. The issue is immediate: Q2 and Q3 profitability hang on a subsidy revision that the company does not control. Management has been honest about the constraints — price hikes taken, production throttled, waiting for policy. The market's 17% drawdown from ATH is fair; it reflects the earnings reality. What's mispriced is the recovery probability — it's not 'if' subsidy gets revised but whether it gets revised *in time* to stabilize Q2–Q3 volumes before seasonal demand peaks and monsoons peak. Watch the government announcement in the next 3–4 weeks. Until then, hold.
Fertiliser margin squeeze drags Coromandel Q1 PAT down 24% YoY despite 16% revenue growth
PAT -23.9% YoY · revenue +15.9% · margins compressing · miss vs street
₹8,164.77 Cr
+15.9% YoY
₹381.56 Cr
-23.9% YoY
4.64%
-2.4pp YoY
₹12.93
Coromandel International reported Q1 FY27 (Jun-2026) consolidated revenue of Rs 8,214.58 Cr, up 15.9% YoY, but net profit fell 23.9% to Rs 381.56 Cr from Rs 501.59 Cr a year ago — a clear case of top-line growth failing to reach the bottom line. Net margin compressed to 4.7% from 7.0%, and operating margin to roughly 7.4% from ~11%. The sequential optics look spectacular (PAT +233% over Q4's Rs 114.64 Cr), but that base was depressed by a Rs 70.56 Cr impairment and by seasonality — Q1 is the peak Kharif fertiliser season while Q4 is a trough — so the QoQ jump is an artifact, not momentum. Standalone tells the cleaner organic story: revenue Rs 7,743.55 Cr (+10.6%) with PAT down 25.8% to Rs 376.96 Cr.
Q1 FY-2027 vs prior quarters
The squeeze sits squarely in the nutrient/fertiliser business, exactly where management warned it would. Standalone nutrient segment result fell to Rs 469.88 Cr from Rs 636.68 Cr (-26%) as elevated raw-material costs (ammonia, phosphoric acid) outran subsidy support — the 'abnormal and fluid' situation flagged on the Q4 concall has now shown up in the P&L. Crop protection was the offset and broadly delivered on guidance: standalone crop-protection revenue rose 20.1% YoY to Rs 870.08 Cr (the low end of the 20-25% guided range), with segment result up 44% to Rs 158.81 Cr. On a consolidated basis crop protection revenue jumped ~72% to Rs 1,250.76 Cr, but a large part of that is inorganic — the NACL Industries acquisition, consolidated from Aug 2025 — and inflates the headline growth rate.
The stock went into the print at ₹2,011.3, up 1.1% over the past month of trading.
Management withheld specific consolidated guidance, citing an 'abnormal and fluid' situation due to a sharp rise in raw material costs from the Middle East crisis, which are not covered by current subsidy rates and are severely compressing fertilizer margins. The company expects to sustain strong performance in its non
— This quarter: met
Against street math this is a miss: the only public model (Univest) mechanically extrapolated ~Rs 753 Cr PAT on ~Rs 10,486 Cr revenue; the actual Rs 382 Cr / Rs 8,215 Cr fell well short, consistent with the margin pressure the company had signalled rather than the trailing-growth assumption analysts pencilled in. Management gave no formal consolidated guidance last quarter, citing the Middle-East-driven cost spike; the crop-protection growth target it did give was met. Alongside the results the board approved housekeeping on overseas/subsidiary structure — a Rs 108 Cr loan-to-equity conversion in wholly-owned Coromandel Chemicals and restructuring of USD 9.7M of loans to Senegal step-down subsidiary BMCC into equity/preference instruments. Auditors S R Batliboi issued an unmodified limited-review conclusion.
W1
Fertiliser margin recovery: nutrient segment result down to Rs 478.91 Cr from Rs 629.48 Cr — watch ammonia/phosphoric-acid costs and subsidy rates next quarter.
W2
Crop protection sustaining the 20-25% guided growth (Rs 870 Cr standalone this quarter) plus organic-vs-NACL contribution split.
W3
July 29 concall for management's updated read on the 'abnormal and fluid' raw-material situation flagged on the Q4 call.
Clean digital PDF; both statements present, column-locked on 30-Jun-2026. No exceptional items this quarter (the Rs 125.15 Cr standalone / Rs 70.56 Cr consolidated impairment sat in Q4 FY26, not the YoY base). Consolidated PAT Rs 381.56 Cr is total; attributable to owners Rs 380.82 Cr, NCI Rs 0.74 Cr. Consolidated YoY not strictly comparable due to NACL Industries consolidation w.e.f. 8-Aug-2025 (crop-protection segment).
Growth masks margin squeeze; subsidy revision now critical
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Crop Protection guidance met (20% within 20-25% band). Subsidy revision—core assumption—not received. PAT significantly missed. Honest about constraints.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong non-subsidy momentum (Crop Protection +20%, Retail +85%) overshadowed by 24% PAT collapse despite 16% revenue growth. Fertilizer margin compression is acute: production throttled to 72% capacity, EBITDA flat, subsidy revision remains pending. Backward integration investments (PA-SA, granulation) position long-term recovery, but near-term subsidy risk is material.
₹8164.8 Cr
Revenue · +15.9% YoY₹381.6 Cr
Reported PAT · −23.9% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Fertilizer business delivered very strong numbers in spite of headwinds
OVERSTATEDRevenue +15.9%, but volumes down 9-10%, EBITDA flat ₹761Cr vs ₹782Cr, PAT -24%
Crop Protection delivered record performance, revenue up 20% to ₹870Cr, EBIT +44% to ₹159Cr
METActual results match claim: ₹870Cr revenue, ₹159Cr EBIT confirmed in numbers
Industry maintained consumption sales volume of phosphatic fertilizer in Q1 vs last year despite subsidy lag
METConsumption was stable, farmers picked lower MRP stocks early; point-of-sales up 13% to 7.9L tons
Backward integration will drive EBITDA per ton from INR5,000 to INR6,500 once normalized
MISSQ1 shows margin compression, not expansion. Target is aspirational; depends on subsidy revision & input price normalization not yet delivered
Earnings quality
What changed since the last call
Subsidy gap widened
DowngradePrior call: '10% subsidy increase'. Q1 reality: rates announced without Middle East crisis factoring. NP/NPK rates do not fully compensate for ammonia, sulphur spikes. Industry production/imports down 21%/38%.
Raw material inflation accelerating
DowngradePrior call: uncertainty on raw material trends. Q1 reality: ammonia/sulphur remain elevated. Phosphoric acid settled Q2 @ $1,700 vs $1,360 Q1 (+25%). Management expects sulphur to stay high 'for some time'.
Crop Protection momentum stronger
UpgradePrior call: optimism on exports. Q1 reality: +20% revenue to ₹870Cr, EBIT +44% to ₹159Cr. Strong pricing power vs cost inflation; product mix improved.
Backward integration tracking
NeutralPA-SA plants commissioned as planned; operations stabilized. Rock phosphate mining (Senegal) producing 1.1L tons (on plan). Granulation on track for Q4. EBITDA/ton uplift deferred to normalized cost environment.
The Q&A
Analysts pressed hard on subsidy adequacy, margin defense, and capex ROI. Management held firm that subsidy revision is policy obligation; resisted cries of demand destruction. Defended capacity moderation as prudent amid high costs. Honest about leverage between pricing actions (already done) and subsidy dependency. Q&A quality: directional but hedged on timelines.
On-ground demand, subsidy gap — Ankur Periwal, Axis Capital
AnsweredNo shortage. Farmers picked up low MRP packs early season; slowdown in monsoon caused slowdown in purchase. Industry taken price actions; subsidy revision now needed to sustain production.
Subsidy revision timeline for Kharif — Ankur Periwal, Axis Capital
PartialIndustry taken max price actions. Beyond that, subsidy revision required. Represented to govt; hopeful outcome coming.
Crop Protection export traction — Ankur Periwal, Axis Capital
Answered3-4 new 9(3) products yearly; 3-4 year pipeline visibility. Latin America presence light now; post-project, plan volume increase via combination products and on-ground presence.
Capital allocation: CDMO vs fertilizer backward integration — Ankur Periwal, Axis Capital
AnsweredSeparate tracks. PA-SA commission handles 60% acid need, comfortable on imports. CDMO organic path via launch plant at Ankleshwar; focus on fluorination for agrochemicals first, then scale to other sectors.
Forex contribution to Crop Protection EBITDA — Himani, ICICI Prudential
AnsweredFollow netting principle, net exposure basis. No more than 5-6% of overall EBITDA attributable to forex.
NACL shareholding increase — Himani, ICICI Prudential
DodgedI wish we can do that.
Capital allocation post PA-SA commissioning — Somaiah, Avendus Spark
AnsweredCompleting investments, want cash generation first. 8-9M tons nutrient capacity visibility for 2 years ahead. Evaluating MAP plant (Kakinada), purified phos acid for battery chemicals. Fertilizer capex deferred; land acquisition ongoing with Andhra Pradesh govt.
NACL margin trajectory — Somaiah, Avendus Spark
AnsweredCurrent portfolio reached reasonable EBITDA level. Moving from 3-4% to 7-8% to 10-11% stages. Further upside requires new products (2-3 year lag). Pursuing intermediates, CDMO to improve margins beyond efficiency gains.
CPC revenue divergence: Coromandel vs NACL — Somaiah, Avendus Spark
AnsweredNACL molecules saw price moderation to global MNCs. Coromandel ability to pass through higher input costs realized better pricing. Reflects product mix difference between two entities.
Sulphur price sustainability — Somaiah, Avendus Spark
AnsweredAgainst expectations, holding high. Likely remain high 'some time' but not sustainable. EV battery demand (nickel leaching) structural shift. These exorbitant levels should soften but may take while. Decided to stay out at these prices; doesn't make economic sense.
Capex target for next 1-2 years — Vivek, DSP Mutual Funds
AnsweredThings change; focused on realizing value from INR7,000Cr invested last 3-4 years. Normal sustainable capex INR300Cr annually, but opportunities-based.
NPK to DAP farmer preference shift — Riju, Antique Stock Broking
AnsweredNo shift happening. DAP high-P (INR1,350/bag) vs 20:20 low-P (INR2,100) doesn't reflect balanced nutrition. If subsidy not corrected for NPK, could have demand destruction risk. Current artificial pricing also impacting. DAP not available beyond volumes; govt encouraging alternates like SSP, organic.
BMCC ramp-up and depreciation spike — Riju, Antique Stock Broking
AnsweredConsolidated depreciation includes mining amortization (overfurden). PA-SA capex depreciation ~INR16-18Cr, NACL intangible amortization ~INR20-21Cr, mining charges ~INR30Cr. Not due to capex alone; mainly mining/amortization expenses.
CP export/domestic mix — Riju, Antique Stock Broking
PartialWill get back to you on specifics.
QR code traceability framework impact — Ranjit, IIFL
AnsweredWitnessed pilot in retail store. QR code links farmer to farm holding/crop type; recommends Urea/DAP/NPK dosage to retailer POS. Farmer restricted to prescribed bags. Win-win: reduces govt subsidy, farmer ensures no N overuse, removes channel arbitrage. Pilot in 10-12 states, 2-3 districts each (Telangana, Karnataka major districts).
EBITDA bridge: consol vs standalone gap — Ranjit, IIFL
AnsweredBMCC mining costs amortized below EBITDA in depreciation line. So consolidated EBITDA shows mining profit, but after amortization, net impact ~INR30Cr. This gap primarily from BMCC.
Request for subsidy/non-subsidy EBITDA split — Ranjit, IIFL
PartialShould do that definitely. Will try to put those in.
Pricing actions taken vs remaining correction needed — Tarang, Old Bridge
Answered25-30% price increase already done across grades this year. Beyond this, impossible; has to come from subsidy. Global raw materials correcting slightly (urea $900→down, ammonia softening, sulphur coming off), but industry calibrated purchases to avoid high-cost carryover. Further price increase not doable.
CP revenue growth drivers amid soft market — Tarang, Old Bridge
AnsweredGlobal agri commodity prices softening, farmer affordability down, cheaper alternatives sought, specialties pushed back. Certain molecules Coromandel deals in not from China; China keeps AIs low, intermediates high. Some markets can absorb price increases. Focusing on B2B exports now; aiming B2C via brands & combinations long-term. AI prices better than earlier.
NPK production decline and subsidy dependency — Dhruv, HDFC AMC
Answered100%. Otherwise doesn't make economic sense for production. Domestic capacities cannot afford to produce at high sulphur/ammonia prices. Critical for subsidy rates to get revised; else production impact Q2 as well.
Nano DAP adoption and regulatory bans — Dhruv, HDFC AMC
AnsweredIdeally yes, but UP and Maharashtra state bans put hold on demand. Without bans, volumes would pick up significantly. Good global response; started exports last quarter. Coming quarters will focus on international Nano business once registrations complete. Nano DAP working well, confident in product.
Subsidy adequacy vs industry cost base — Prashant, Elara Capital
PartialLet subsidy come then derive EBITDA per ton. Seeking 6-month average rate per policy, not ad-hoc. No plant can sustain this cost increase in global environment without policy-defined average.
QR code impact on balanced nutrition demand — Prashant, Elara Capital
AnsweredUrea and DAP will be curtailed under QR framework. Ideally should increase NP/NPK demand (better balanced nutrition), but not yet happening at scale.
CP expansion and capacity utilization — Prashant, Elara Capital
AnsweredJust completing capacity expansion. Want to focus on cash generation. Won't add AI capacities (spare in NACL available); leverage capacity between both plants. Investment more toward marketing, brand building, channel network vs asset creation.
BMCC capex and SSP facility plans — Prashant, Elara Capital
AnsweredOperating plant at target 5L tons rock phosphate production per plan. Want to invest in SSP facility (doesn't cost much $5-6M for 100-150K tons). Huge opportunity using reject rocks; adds value on phosphate in Senegal, can export regionally. If successful at smaller scale, may expand to capture more value in Senegal.
Subsidy delay causes — Darshita Shah, DSP Asset Managers
AnsweredPressure on overall subsidy bill across categories. Govt cost-passes Urea fully (higher gas prices), DAP compensated fully. Pushback on NP/NPK due to budget constraints. Industry represented; awaiting outcome.
New market entry strategy post granulation — Darshita Shah, DSP Asset Managers
AnsweredCapacity 750K tons. Want to sell 50% via retail outlets (increasing footprint Maharashtra, Tamil Nadu, Andhra Pradesh, Telangana). Balance 50% (350-400K tons) seeding markets UP, Rajasthan, MP, Chhattisgarh. No challenge in absorbing additional volume.
Subsidy as policy vs ad-hoc support — Naushad Chaudhary, Aditya Birla Mutual Fund
AnsweredSeeking policy-defined 6-month average rate for NBS, not ad-hoc subsidy like DAP/Urea. NP/NPK predominantly produced in India. Not asking for additional support; seeking what policy defines.
Capex ROI and EBITDA per ton uplift — Nirav, Anvil Wealth
AnsweredAverage EBITDA per ton needs to go from INR5,000 to INR6,500. Rest of capex toward Senegal or CP new capacity. CP margins show payback <3 years on some capex.
Specialty Nutrients contribution to FY26 EBITDA — Nirav, Anvil Wealth
AnsweredNo separate number provided. Continuously growing topline 25-30%, EBITDA margin 20%. Sulphur expansion not helped yet due to current situation (temporary). Pursuing MAP plant, seaweed/gypsum granulation. Business growing well.
SSP business per-ton contribution — Nirav, Anvil Wealth
AnsweredINR2,500 to INR3,000 per ton.
Dhaksha drone subsidiary performance — Vipulkumar, Sumangal Investment
AnsweredFocusing agri drones, gained good traction. Coromandel purchased 100-150 drones Q1, plan 500-drone fleet during year. Dhaksha will cater to agri-drones. Defense orders in final stage; once materialize, scale up. Not very significant EBITDA drag currently.
NPK EBITDA per ton target — Vipulkumar, Sumangal Investment
AnsweredYes, once commercialize plant in steady state in normal situation. Don't expect this quarter (spurt in input prices). Once normalcy restores, should realize it.
Optimal sulphur price for backward integration viability — Sandeep Mukherjee, SKP Securities
AnsweredGiven phosphoric acid at $1,700, at least want $800 sulphur pricing.
Guidance
Capacity visibility: 8-9M tons nutrients + 1M tons trading (DAP) over next 2 years
HighPost PA-SA/granulation commissioning. Excludes unforeseen subsidy/geopolitical shocks. Includes fertilizer + SSP + organic + Urea + imported DAP.
Crop Protection: Latin America expansion via Mancozeb combination products & on-ground presence post capex
MediumTimeline: 2-3 year horizon. Dependent on successful molecule positioning and MNC partnerships (CDMO strategy underway).
Retail: 50% of 750K ton capacity via own outlets (maximizing existing markets); 50% via wholesale in UP, Raj, MP, CG
HighMarket seeding already underway. No absorption challenge flagged. Organic network expansion model (low capex).
Fertilizer EBITDA per ton: INR5,000 → INR6,500 (30% uplift) via backward integration (PA-SA acid security + imported cost arbitrage)
LowDependent on subsidy rate normalization and input cost stabilization. Q1 shows compression, not expansion. Management cautious: 'don't ask for this quarter; normal situation required'.
Crop Protection: <3 year capex payback on select investments; improved product mix & pricing power sustaining 40%+ EBIT growth
MediumContingent on continued export momentum and ability to pass-through raw material inflation (demonstrated Q1).
Specialty Nutrients: 25-30% topline growth, 20% EBITDA margin (structural level). Sulphur expansion underutilized temporarily
MediumDependent on farmer adoption of water-soluble grades (drip irrigation uptake) and premium product mix (granulation launches).
Sustainable annual capex: INR300Cr run-rate post-completion of PA-SA/granulation/capacity expansion projects
HighMaintenance + selective opportunities. Last 3-4 years invested INR7,000Cr (organic + NACL inorganic); focus now on cash generation from these assets.
Senegal SSP facility: $5-6M capex for 100-150K ton capacity; scaling dependent on success at smaller pilot level
MediumStrategic to utilize reject rocks and capture value addition in Senegal. Decision point tied to pilot results.
MAP plant (Kakinada): To come up after 1 year or so for raw material security + trading opportunity in specialty nutrients
MediumTiming flexible; dependent on market conditions and internal cash generation priorities.
Risks the call surfaced
Subsidy-Margin Misalignment
HighGovernment NBS subsidy rates (10% increase announced) do not factor Middle East crisis raw material inflation (ammonia, sulphur). NP/NPK rates inadequate; management seeking 6-month average per policy but revision pending. Without revision, fertilizer EBITDA unsustainable; further production cuts likely.
Raw Material Inflation
HighSulphur, ammonia, phosphoric acid prices elevated due to West Asia geopolitical disruptions and supply cuts by major manufacturers. Phosphoric acid Q2 settled at $1,700 (vs $1,360 Q1, +25%). Sulphur expected to remain high 'for some time.' Price pass-through limited by subsidy cap and farmer affordability.
Volume/Demand Elasticity
MediumFertilizer sales volumes moderated 9-10% Q1 despite company market share gains (22% primary vs 18%). Production throttled to 72% capacity utilization. Risk: if subsidy not revised and prices further hiked, demand destruction among price-sensitive farmers; could exceed current 10% volume decline.
Monsoon Dependency
MediumIndia experienced 23% deficit rainfall (long-period average) in Q1. Reservoir levels 34% of capacity vs 57% prior year. While sowing improved in July (deficit moderated to 17%), continued drought risk could dampen kharif demand and fertilizer offtake in Q2.
Regulatory/State Bans
LowNano DAP and Nano Urea banned by state governments in UP and Maharashtra (major agricultural states). Constrains adoption of these alternate fertilizers despite strong farmer response and subsidy cost-saving potential. Risk: further state-level bans or delayed approval could cap Nano category growth.
Management
Score 7/10. Transparent on constraints (subsidy lag, raw material inflation). Repeated subsidy dependency theme; honest about limited pricing room. Some hedging on subsidy revision certainty ('hopeful'). Technical depth strong (cost breakdowns, capacity planning). Avoids hype; grounded in numbers. PA-SA/granulation projects tracking as planned (positive track record). NACL integration progressing to target margins (positive). But PAT down 23.9% despite prior confidence in 'resilient performance'—disconnect between narrative and delivery on profitability.
1 · Aug-Sep 2026
Kharif subsidy revision announcement; phosphoric acid Q2 @ $1,700 vs $1,360 Q1
2 · Q4 FY27
Granulation project commissioning; capacity headroom for fertilizer volumes
3 · FY27-FY28
Sulphuric acid plant ramp-up; backward integration margin bridge to INR6,500/ton
Backward integration investments (PA-SA, granulation) position long-term recovery, but near-term subsidy risk is material.